DePaul University researchers can submit protocols for research involving recombinant or synthetic nucleic acid molecules and biohazardous agents through the eProtocol system. All initial protocols, amendments, and final reports utilize this system.
Before submitting an application, please follow the below protocol preparation guidelines:
- If this is your first time going through the IBC, please review the Getting Started webpage.
- Determine the risk level of the agent and the Biosafety Containment Level (BSL). Currently, only research or teaching activities meeting the criteria for either BSL 1 or 2 containment procedures can be conducted at DePaul University. Information on the BSL and Risk Group Levels can be found in the Risk Groups & Biosafety webpage.
Other Documents & Resources
Guidance and Education for Receipt of and Transport of Biohazardous Materials
This document provides guidance for DePaul faculty, staff, or students who are responsible for receiving shipments of potentially biohazardous materials or who transport biohazardous materials on campus.
Hepatitis B Vaccination Statement
This form is to be used to document receipt of the hepatitis B vaccination, declination of the hepatitis B vaccination, or the desire to receive the Hepatitis B vaccination through DePaul. This form must be completed by all personnel working on a protocol with potential blood borne pathogen exposure as potential risk.
This document provides background information as to why the IBC requires that personnel who have exposure to human blood or other agents that may contain blood borne pathogens need to complete the Hepatitis B Vaccination/Declination Statement and submit that document with the IBC protocol materials to the IBC.
Generic Vaccination/Declination Form
Use this form when your work requires a vaccination with something other than the Hepatitis B vaccination series. This form can be edited to any vaccination type.